TickerFactsScreenerDevelopers

ACRO BIOMEDICAL CO., LTD. (ACBM) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $459.0K2018: $7.18M2019: $181.4K2020: $528.6K2021: $938.0K2022: $518.0K2023: $0$0
2017Cost of Revenue (USD)2023
Fiscal YearCost of RevenueChange YoY
2023$0-100.0%
2022$518.0K-44.8%
2021$938.0K+77.5%
2020$528.6K+191.3%
2019$181.4K-97.5%
2018$7.18M+1464.5%
2017$459.0K—